Our community of experts has identified a set of common digital clinical measures that are essential for developing Cytokine Release Syndrome (CRS) de-risking products.

We’ve also developed an ontology to help you standardize data collection for assessing CRS onset and severity, whether you’re collecting data manually or digitally, in inpatient or outpatient settings.

These resources are designed to help you streamline data collection efforts, supporting the development of more efficient CRS de-risking products and risk prediction models.

Use these measures—fever generation, tachycardia, hypotension, and hypoxia—to detect CRS early, capture critical data, and take action before complications arise, prioritizing patient safety and reducing risks.